Home
>
National Drug Code (NDC)
>
CORZIDE
CORZIDE - 60793-283-01 - (nadolol and bendroflumethiazide)
Drug Information of CORZIDE
| Product NDC: | 60793-283 |
| Proprietary Name: | CORZIDE |
| Non Proprietary Name: | nadolol and bendroflumethiazide |
| Active Ingredient(s): | 5; 40 mg/1; mg/1 & nbsp; nadolol and bendroflumethiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CORZIDE
| Product NDC: | 60793-283 |
| Labeler Name: | King Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018647 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19830525 |
Package Information of CORZIDE
| Package NDC: | 60793-283-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (60793-283-01) |
NDC Information of CORZIDE
| NDC Code | 60793-283-01 |
| Proprietary Name | CORZIDE |
| Package Description | 100 TABLET in 1 BOTTLE (60793-283-01) |
| Product NDC | 60793-283 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | nadolol and bendroflumethiazide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19830525 |
| Marketing Category Name | NDA |
| Labeler Name | King Pharmaceuticals, Inc. |
| Substance Name | BENDROFLUMETHIAZIDE; NADOLOL |
| Strength Number | 5; 40 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
